Reprogramming somatic cells towards pluripotency by cellular fusion

Current Opinion in Genetics and Development

Volumn 22, Issue 5, 2012, Pages 459-465

  Soza Ried, Jorge ^a   Fisher, Amanda G ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; MACROGOL; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR;

CELL DIFFERENTIATION; CELL FUSION; CELL HYBRIDIZATION; CELL LINEAGE; CELL NUCLEUS TRANSPLANTATION; CELL STRUCTURE; CELL TRANSFORMATION; CELL TYPE; DNA METHYLATION; EMBRYONAL CARCINOMA STEM CELL; EMBRYONIC STEM CELL; EPIGENETICS; GERM LAYER; HETEROKARYON; HUMAN; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SOMATIC CELL; THYMOCYTE;

ANIMALS; CELL DIFFERENTIATION; CELL FUSION; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; EPIGENOMICS; HUMANS; NUCLEAR REPROGRAMMING; NUCLEAR TRANSFER TECHNIQUES; PLURIPOTENT STEM CELLS; TRANSCRIPTION FACTORS;

MAMMALIA;

EID: 84868204914     PISSN: 0959437X     EISSN: 18790380     Source Type: Journal    
DOI: 10.1016/j.gde.2012.07.005     Document Type: Review

References (64)

1. Harris H., Miller O.J., Klein G., Worst P., Tachibana T. Suppression of malignancy by cell fusion. Nature 1969, 223:363-368.
2. Pontecorvo G. Production of mammalian somatic cell hybrids by means of polyethylene glycol treatment. Somatic Cell Genet 1975, 1:397-400.
3. Miller R.A., Ruddle F.H. Pluripotent teratocarcinoma-thymus somatic cell hybrids. Cell 1976, 9:45-55.
4. Teissie J., Knutson V.P., Tsong T.Y., Lane M.D. Electric pulse-induced fusion of 3T3 cells in monolayer culture. Science 1982, 216:537-538.
5. Long M.A., Rossi F.M. Targeted cell fusion facilitates stable heterokaryon generation in vitro and in vivo. PLoS One 2011, 6:e26381.
6. Rao P.N., Johnson R.T. Mammalian cell fusion: studies on the regulation of DNA synthesis and mitosis. Nature 1970, 225:159-164.
7. Pereira C.F., Terranova R., Ryan N.K., Santos J., Morris K.J., Cui W., Merkenschlager M., Fisher A.G. Heterokaryon-based reprogramming of human B lymphocytes for pluripotency requires Oct4 but not Sox2. PLoS Genet 2008, 4:e1000170.
8. Blau H.M., Chiu C.P., Webster C. Cytoplasmic activation of human nuclear genes in stable heterocaryons. Cell 1983, 32:1171-1180.
9. Terranova R., Pereira C.F., Du Roure C., Merkenschlager M., Fisher A.G. Acquisition and extinction of gene expression programs are separable events in heterokaryon reprogramming. J Cell Sci 2006, 119:2065-2072.
10. Pomerantz J.H., Mukherjee S., Palermo A.T., Blau H.M. Reprogramming to a muscle fate by fusion recapitulates differentiation. J Cell Sci 2009, 122:1045-1053.
11. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
12. Yamanaka S. A fresh look at iPS cells. Cell 2009, 137:13-17.
13. Hanna J., Saha K., Pando B., van Zon J., Lengner C.J., Creyghton M.P., van Oudenaarden A., Jaenisch R. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 2009, 462:595-601.
14. Anokye-Danso F., Trivedi C.M., Juhr D., Gupta M., Cui Z., Tian Y., Zhang Y., Yang W., Gruber P.J., Epstein J.A., et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 2011, 8:376-388.
15. Plath K., Lowry W.E. Progress in understanding reprogramming to the induced pluripotent state. Nat Rev Genet 2011, 12:253-265.
16. Smith Z.D., Nachman I., Regev A., Meissner A. Dynamic single-cell imaging of direct reprogramming reveals an early specifying event. Nat Biotechnol 2010, 28:521-526.
17. Noggle S., Fung H.L., Gore A., Martinez H., Satriani K.C., Prosser R., Oum K., Paull D., Druckenmiller S., Freeby M., et al. Human oocytes reprogram somatic cells to a pluripotent state. Nature 2011, 478:70-75.
18. Chen Y., He Z.X., Liu A., Wang K., Mao W.W., Chu J.X., Lu Y., Fang Z.F., Shi Y.T., Yang Q.Z., et al. Embryonic stem cells generated by nuclear transfer of human somatic nuclei into rabbit oocytes. Cell Res 2003, 13:251-263.
19. Blelloch R., Wang Z., Meissner A., Pollard S., Smith A., Jaenisch R. Reprogramming efficiency following somatic cell nuclear transfer is influenced by the differentiation and methylation state of the donor nucleus. Stem Cells 2006, 24:2007-2013.
20. Cowan C.A., Atienza J., Melton D.A., Eggan K. Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 2005, 309:1369-1373.
21. Silva J., Chambers I., Pollard S., Smith A. Nanog promotes transfer of pluripotency after cell fusion. Nature 2006, 441:997-1001.
22. Bhutani N., Brady J.J., Damian M., Sacco A., Corbel S.Y., Blau H.M. Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature 2010, 463:1042-1047.
23. Piccolo F.M., Pereira C.F., Cantone I., Brown K., Tsubouchi T., Soza-Ried J., Merkenschlager M., Fisher A.G. Using heterokaryons to understand pluripotency and reprogramming. Phil Trans R Soc Lond B: Biol Sci 2011, 366:2260-2265.
24. Tada M., Takahama Y., Abe K., Nakatsuji N., Tada T. Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr Biol 2001, 11:1553-1558.
25. Han D.W., Do J.T., Gentile L., Stehling M., Lee H.T., Scholer H.R. Pluripotential reprogramming of the somatic genome in hybrid cells occurs with the first cell cycle. Stem Cells 2008, 26:445-454.
26. Kim J.B., Greber B., Arauzo-Bravo M.J., Meyer J., Park K.I., Zaehres H., Scholer H.R. Direct reprogramming of human neural stem cells by OCT4. Nature 2009, 461:649-653.
27. Miller R.A., Ruddle F.H. Properties of teratocarcinoma-thymus somatic cell hybrids. Somatic Cell Genet 1977, 3:247-261.
28. Sumer H., Nicholls C., Pinto A.R., Indraharan D., Liu J., Lim M.L., Liu J.P., Verma P.J. Chromosomal and telomeric reprogramming following ES-somatic cell fusion. Chromosoma 2010, 119:167-176.
29. Tada M., Tada T., Lefebvre L., Barton S.C., Surani M.A. Embryonic germ cells induce epigenetic reprogramming of somatic nucleus in hybrid cells. EMBO J 1997, 16:6510-6520.
30. Santos J., Pereira C.F., Di-Gregorio A., Spruce T., Alder O., Rodriguez T., Azuara V., Merkenschlager M., Fisher A.G. Differences in the epigenetic and reprogramming properties of pluripotent and extra-embryonic stem cells implicate chromatin remodelling as an important early event in the developing mouse embryo. Epigenet Chromatin 2010, 3:1.
31. Do J.T., Scholer H.R. Nuclei of embryonic stem cells reprogram somatic cells. Stem Cells 2004, 22:941-949.
32. Foshay K.M., Looney T.J., Chari S., Mao F.F., Lee J.H., Zhang L., Fernandes C.J., Baker S.W., Clift K.L., Gaetz J., et al. Embryonic stem cells induce pluripotency in somatic cell fusion through biphasic reprogramming. Mol Cell 2012, 46:159-170.
33. Theunissen T.W., van Oosten A.L., Castelo-Branco G., Hall J., Smith A., Silva J.C. Nanog overcomes reprogramming barriers and induces pluripotency in minimal conditions. Curr Biol 2011, 21:65-71.
34. Theunissen T.W., Costa Y., Radzisheuskaya A., van Oosten A.L., Lavial F., Pain B., Castro L.F., Silva J.C. Reprogramming capacity of Nanog is functionally conserved in vertebrates and resides in a unique homeodomain. Development 2011, 138:4853-4865.
35. Hirai H., Tani T., Katoku-Kikyo N., Kellner S., Karian P., Firpo M., Kikyo N. Radical acceleration of nuclear reprogramming by chromatin remodeling with the transactivation domain of MyoD. Stem Cells 2011, 29:1349-1361.
36. Forcales S.V., Albini S., Giordani L., Malecova B., Cignolo L., Chernov A., Coutinho P., Saccone V., Consalvi S., Williams R., et al. Signal-dependent incorporation of MyoD-BAF60c into Brg1-based SWI/SNF chromatin-remodelling complex. EMBO J 2012, 31:301-316.
37. Hezroni H., Tzchori I., Davidi A., Mattout A., Biran A., Nissim-Rafinia M., Westphal H., Meshorer E. H3K9 histone acetylation predicts pluripotency and reprogramming capacity of ES cells. Nucleus 2011, 2:300-309.
38. Pereira C.F., Piccolo F.M., Tsubouchi T., Sauer S., Ryan N.K., Bruno L., Landeira D., Santos J., Banito A., Gil J., et al. ESCs require PRC2 to direct the successful reprogramming of differentiated cells toward pluripotency. Cell Stem Cell 2010, 6:547-556.
39. Pasque V., Gillich A., Garrett N., Gurdon J.B. Histone variant macroH2A confers resistance to nuclear reprogramming. EMBO J 2011, 30:2373-2387.
40. Mali P., Chou B.K., Yen J., Ye Z., Zou J., Dowey S., Brodsky R.A., Ohm J.E., Yu W., Baylin S.B., et al. Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Stem Cells 2010, 28:713-720.
41. Onder T.T., Kara N., Cherry A., Sinha A.U., Zhu N., Bernt K.M., Cahan P., Mancarci O.B., Unternaehrer J., Gupta P.B., et al. Chromatin-modifying enzymes as modulators of reprogramming. Nature 2012, 483:598-602.
42. Mikkelsen T.S., Hanna J., Zhang X., Ku M., Wernig M., Schorderet P., Bernstein B.E., Jaenisch R., Lander E.S., Meissner A. Dissecting direct reprogramming through integrative genomic analysis. Nature 2008, 454:49-55.
43. Huangfu D., Maehr R., Guo W., Eijkelenboom A., Snitow M., Chen A.E., Melton D.A. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 2008, 26:795-797.
44. Singhal N., Graumann J., Wu G., Arauzo-Bravo M.J., Han D.W., Greber B., Gentile L., Mann M., Scholer H.R. Chromatin-remodeling components of the BAF complex facilitate reprogramming. Cell 2010, 141:943-955.
45. Lluis F., Pedone E., Pepe S., Cosma M.P. Periodic activation of Wnt/beta-catenin signaling enhances somatic cell reprogramming mediated by cell fusion. Cell Stem Cell 2008, 3:493-507.
46. Marson A., Foreman R., Chevalier B., Bilodeau S., Kahn M., Young R.A., Jaenisch R. Wnt signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell 2008, 3:132-135.
47. Lluis F., Ombrato L., Pedone E., Pepe S., Merrill B.J., Cosma M.P. T-cell factor 3 (Tcf3) deletion increases somatic cell reprogramming by inducing epigenome modifications. Proc Natl Acad Sci U S A 2011, 108:11912-11917.
48. Ombrato L., Lluis F., Cosma M.P. Regulation of self-renewal and reprogramming by TCF factors. Cell Cycle 2012, 11:39-47.
49. Blau H.M., Baltimore D. Differentiation requires continuous regulation. J Cell Biol 1991, 112:781-783.
50. Medvedovic J., Ebert A., Tagoh H., Busslinger M. Pax5: a master regulator of B cell development and leukemogenesis. Adv Immunol 2011, 111:179-206.
51. Kruglova A.A., Matveeva N.M., Gridina M.M., Battulin N.R., Karpov A., Kiseleva E.V., Morozova K.N., Serov O.L. Dominance of parental genomes in embryonic stem cell/fibroblast hybrid cells depends on the ploidy of the somatic partner. Cell Tissue Res 2010, 340:437-450.
52. Palermo A., Doyonnas R., Bhutani N., Pomerantz J., Alkan O., Blau H.M. Nuclear reprogramming in heterokaryons is rapid, extensive, and bidirectional. FASEB J 2009, 23:1431-1440.
53. Cell Fusion: The Dunham Lectures 1970, Harvard University Press, Cambridge, MA. H. Harris (Ed.).
54. Hollenberg S.M., Cheng P.F., Weintraub H. Use of a conditional MyoD transcription factor in studies of MyoD trans-activation and muscle determination. Proc Natl Acad Sci U S A 1993, 90:8028-8032.
55. Xie H., Ye M., Feng R., Graf T. Stepwise reprogramming of B cells into macrophages. Cell 2004, 117:663-676.
56. Rodriguez-Ubreva J., Ciudad L., Gomez-Cabrero D., Parra M., Bussmann L.H., di Tullio A., Kallin E.M., Tegner J., Graf T., Ballestar E. Pre-B cell to macrophage transdifferentiation without significant promoter DNA methylation changes. Nucleic Acids Res 2012, 40:1954-1968.
57. Johnson R.T., Rao P.N. Mammalian cell fusion: induction of premature chromosome condensation in interphase nuclei. Nature 1970, 226:717-722.
58. Sullivan S., Pells S., Hooper M., Gallagher E., McWhir J. Nuclear reprogramming of somatic cells by embryonic stem cells is affected by cell cycle stage. Cloning Stem Cells 2006, 8:174-188.
59. Ganier O., Bocquet S., Peiffer I., Brochard V., Arnaud P., Puy A., Jouneau A., Feil R., Renard J.P., Mechali M. Synergic reprogramming of mammalian cells by combined exposure to mitotic Xenopus egg extracts and transcription factors. Proc Natl Acad Sci U S A 2011, 108:17331-17336.
60. Skelley A.M., Kirak O., Suh H., Jaenisch R., Voldman J. Microfluidic control of cell pairing and fusion. Nat Methods 2009, 6:147-152.
61. Gel M., Kimura Y., Kurosawa O., Oana H., Kotera H., Washizu M. Dielectrophoretic cell trapping and parallel one-to-one fusion based on field constriction created by a micro-orifice array. Biomicrofluidics 2010, 4:228081-228088.
62. Kimura Y., Gel M., Techaumnat B., Oana H., Kotera H., Washizu M. Dielectrophoresis-assisted massively parallel cell pairing and fusion based on field constriction created by a micro-orifice array sheet. Electrophoresis 2011, 32:2496-2501.
63. Hu N., Yang J., Yin Z.Q., Ai Y., Qian S., Svir I.B., Xia B., Yan J.W., Hou W.S., Zheng X.L. A high-throughput dielectrophoresis-based cell electrofusion microfluidic device. Electrophoresis 2011, 32:2488-2495.
64. Holzer T., Liffers K., Rahm K., Trageser B., Ozbek S., Gradl D. Live imaging of active fluorophore labelled Wnt proteins. FEBS Lett 2012, 586:1638-1644.